Brief: Royal Bank Of Canada's Long Position In H-Shares Of Haohai Biological Rises To 6.15% - Filing
30/06/2022 10:27
June 30 (Reuters) - Hong Kong stock exchange filing:
* ROYAL BANK OF CANADA'S LONG POSITION IN H-SHARES OF
SHANGHAI
HAOHAI BIOLOGICAL TECHNOLOGY 6826.HK INCREASED TO 6.15% ON
JUNE 27 FROM 5.96% - HKEX FILING
Source text https://di.hkex.com.hk/di/NSForm2.aspx?fn=CS20220629E00559&sa2=ns&sid=119410&sd=30/06/2021&ed=30/06/2022&sa1=cl&scsd=30/06/2021&sced=30/06/2022&sc=06826&src=Main&lang=EN&tk=ds
Further company coverage: 6826.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.